BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 16267045)

  • 21. Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells.
    Rhyu DY; Yang Y; Ha H; Lee GT; Song JS; Uh ST; Lee HB
    J Am Soc Nephrol; 2005 Mar; 16(3):667-75. PubMed ID: 15677311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.
    Samarakoon R; Higgins CE; Higgins SP; Kutz SM; Higgins PJ
    J Cell Physiol; 2005 Jul; 204(1):236-46. PubMed ID: 15622520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of TGF-β Signaling in Tumor Cells by Small Molecule Src Family Kinase Inhibitors.
    Bartscht T; Rosien B; Rades D; Kaufmann R; Biersack H; Lehnerta H; Ungefroren H
    Anticancer Agents Med Chem; 2017; 17(10):1351-1356. PubMed ID: 28044939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
    Yang J; Dai C; Liu Y
    J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TGF-β Signal Transduction in Pancreatic Carcinoma Cells is Sensitive to Inhibition by the Src Tyrosine Kinase Inhibitor AZM475271.
    Bartscht T; Rosien B; Rades D; Kaufmann R; Biersack H; Lehnert H; Ungefroren H
    Anticancer Agents Med Chem; 2017; 17(7):966-972. PubMed ID: 27671303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetic characterization of novel pyrazole TGF-beta receptor I kinase inhibitors and their blockade of the epithelial-mesenchymal transition.
    Peng SB; Yan L; Xia X; Watkins SA; Brooks HB; Beight D; Herron DK; Jones ML; Lampe JW; McMillen WT; Mort N; Sawyer JS; Yingling JM
    Biochemistry; 2005 Feb; 44(7):2293-304. PubMed ID: 15709742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542.
    Laping NJ; Grygielko E; Mathur A; Butter S; Bomberger J; Tweed C; Martin W; Fornwald J; Lehr R; Harling J; Gaster L; Callahan JF; Olson BA
    Mol Pharmacol; 2002 Jul; 62(1):58-64. PubMed ID: 12065755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of EGF receptor and c-Src in the survival signals induced by TGF-beta1 in hepatocytes.
    Murillo MM; del Castillo G; Sánchez A; Fernández M; Fabregat I
    Oncogene; 2005 Jun; 24(28):4580-7. PubMed ID: 15856020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Src phosphorylates Tyr284 in TGF-beta type II receptor and regulates TGF-beta stimulation of p38 MAPK during breast cancer cell proliferation and invasion.
    Galliher AJ; Schiemann WP
    Cancer Res; 2007 Apr; 67(8):3752-8. PubMed ID: 17440088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.
    Fanayan S; Firth SM; Baxter RC
    J Biol Chem; 2002 Mar; 277(9):7255-61. PubMed ID: 11751851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autophagy links β-catenin and Smad signaling to promote epithelial-mesenchymal transition via upregulation of integrin linked kinase.
    Pang M; Wang H; Rao P; Zhao Y; Xie J; Cao Q; Wang Y; Wang YM; Lee VW; Alexander SI; Harris DC; Zheng G
    Int J Biochem Cell Biol; 2016 Jul; 76():123-34. PubMed ID: 27177845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cigarette smoke-induced EGFR activation promotes epithelial mesenchymal migration of human retinal pigment epithelial cells through regulation of the FAK-mediated Syk/Src pathway.
    Park GB; Kim D
    Mol Med Rep; 2018 Mar; 17(3):3563-3574. PubMed ID: 29286114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Collaborative activities of macrophage-stimulating protein and transforming growth factor-beta1 in induction of epithelial to mesenchymal transition: roles of the RON receptor tyrosine kinase.
    Wang D; Shen Q; Chen YQ; Wang MH
    Oncogene; 2004 Mar; 23(9):1668-80. PubMed ID: 15001985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual inhibition of Src family kinases and Aurora kinases by SU6656 modulates CTGF (connective tissue growth factor) expression in an ERK-dependent manner.
    Cicha I; Zitzmann R; Goppelt-Struebe M
    Int J Biochem Cell Biol; 2014 Jan; 46():39-48. PubMed ID: 24275091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The ALK-5 inhibitor A-83-01 inhibits Smad signaling and epithelial-to-mesenchymal transition by transforming growth factor-beta.
    Tojo M; Hamashima Y; Hanyu A; Kajimoto T; Saitoh M; Miyazono K; Node M; Imamura T
    Cancer Sci; 2005 Nov; 96(11):791-800. PubMed ID: 16271073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transforming growth factor-beta1 protects against pulmonary artery endothelial cell apoptosis via ALK5.
    Lu Q
    Am J Physiol Lung Cell Mol Physiol; 2008 Jul; 295(1):L123-33. PubMed ID: 18456797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transforming growth factor beta activation of c-Abl is independent of receptor internalization and regulated by phosphatidylinositol 3-kinase and PAK2 in mesenchymal cultures.
    Wilkes MC; Leof EB
    J Biol Chem; 2006 Sep; 281(38):27846-54. PubMed ID: 16867995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel aminothiazole KY-05009 with potential to inhibit Traf2- and Nck-interacting kinase (TNIK) attenuates TGF-β1-mediated epithelial-to-mesenchymal transition in human lung adenocarcinoma A549 cells.
    Kim J; Moon SH; Kim BT; Chae CH; Lee JY; Kim SH
    PLoS One; 2014; 9(10):e110180. PubMed ID: 25337707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular heparan sulfate negatively modulates transforming growth factor-beta1 (TGF-beta1) responsiveness in epithelial cells.
    Chen CL; Huang SS; Huang JS
    J Biol Chem; 2006 Apr; 281(17):11506-14. PubMed ID: 16492675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral administration of GW788388, an inhibitor of TGF-beta type I and II receptor kinases, decreases renal fibrosis.
    Petersen M; Thorikay M; Deckers M; van Dinther M; Grygielko ET; Gellibert F; de Gouville AC; Huet S; ten Dijke P; Laping NJ
    Kidney Int; 2008 Mar; 73(6):705-15. PubMed ID: 18075500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.